Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study.
| Τίτλος: | Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study. |
|---|---|
| Συγγραφείς: | Sorbye H; Cancer Clinic, Haukeland University Hospital, Bergen, Norway. halfdan.sorbye@helse-bergen.no.; Department of Clinical Science, University of Bergen, Bergen, Norway. halfdan.sorbye@helse-bergen.no., Hjortland GO; Department of Oncology, Oslo University Hospital, Oslo, Norway., Vestermark LW; Department of Oncology, University Hospital of Southern Denmark, Esbjerg, Denmark., Ladekarl M; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.; Department of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, and Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Svensson J; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Sundlöv A; Department of Oncology, Skåne University Hospital, Lund, Sweden., Janson ET; Department of Medical Sciences, Section of Endocrine Oncology, Uppsala University, Uppsala, Sweden., Garresori H; Department of Oncology, Stavanger University Hospital, Stavanger, Norway., Hofsli E; Department of Oncology, St.Olavs Hospital, Trondheim, Norway., Kersten C; Department of Research, Hospital of Southern Norway, Kristiansand, Norway., Elvebakken H; Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway., Pfeiffer P; Department of Oncology, Odense University Hospital, Odense, Denmark., Morken S; Cancer Clinic, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Assmus J; Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway., Lothe IMB; Department of Pathology, Oslo University Hospital, Oslo, Norway., Tabaksblat E; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Knigge U; Department of Surgery C and Endocrinology PE, Rigshospitalet, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark., Couvelard A; Department of Pathology, Bichat Hospital, Paris, France., Perren A; Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland., Langer SW; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. |
| Πηγή: | British journal of cancer [Br J Cancer] 2025 Aug; Vol. 133 (3), pp. 420. |
| Τύπος έκδοσης: | Published Erratum |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE; PubMed not MEDLINE |
| Imprint Name(s): | Publication: 2002- : London : Nature Publishing Group on behalf of Cancer Research UK Original Publication: London, Lewis. |
| Σχόλια: | Erratum for: Br J Cancer. 2025 Aug;133(3):316-324. doi: 10.1038/s41416-025-03054-w.. (PMID: 40382522) |
| Entry Date(s): | Date Created: 20250714 Latest Revision: 20250807 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC12322100 |
| DOI: | 10.1038/s41416-025-03095-1 |
| PMID: | 40659859 |
| Βάση Δεδομένων: | MEDLINE |
καταχωρήστε σχόλιο πρώτοι!